Biogen Plans Innovative Headquarters in Kendall Square
Biogen Inc. (Nasdaq: BIIB) has made a significant announcement regarding its plans for a new global headquarters at Kendall Common. This move is part of a broader multi-year strategy aimed at optimizing its real estate footprint in Massachusetts.
A Modern Hub for Collaboration
The company has signed a lease for the new facility, which will cover approximately 580,000 square feet of space that combines office and research and development areas. Set to open in 2028, the headquarters will serve as an innovation hub designed to foster collaboration among Biogen's scientific teams, partners, and talent from around the world.
Christopher A. Viehbacher, President and Chief Executive Officer at Biogen, expressed his excitement, stating, "Nearly 50 years after first putting down roots in Kendall Square, Biogen is embarking on a new chapter in the very heart of the community that has shaped our success.” He emphasized that the new facility aims to bring employees together to facilitate groundbreaking research and development activities.
Emphasizing Sustainability and Innovation
The state-of-the-art building will feature advanced design elements that prioritize sustainability. It will include modern laboratories and upgraded workspaces, equipped with energy-efficient systems and water conservation technologies, reflecting Biogen's commitment to responsible practices.
A Community-Focused Initiative
In addition to fostering innovation, the new headquarters will include the Biogen CoLab, a collaborative space aimed at promoting education and career readiness in life sciences. This initiative will offer community members and students opportunities to engage with Biogen’s scientists and gain valuable insights into careers in healthcare.
Reinforcing Massachusetts’ Role in Biotechnology
Biogen's presence has long been a cornerstone of the Massachusetts life sciences ecosystem. The new headquarters signifies another step in reinforcing the state's reputation as a leading center for biotechnology and life sciences.
Governor Maura Healey commented on the significance of Biogen's long-standing commitment to the region, celebrating the company's role in advancing innovative treatments and creating job opportunities for the community.
A Legacy of Excellence
Since its founding in 1978, Biogen has consistently been at the forefront of the biotechnology industry. The company's focus on pioneering scientific advancements to deliver cutting-edge treatments continues to transform the lives of patients worldwide.
Looking Ahead: Biogen's Vision
As Biogen prepares for this exciting new chapter, it remains dedicated to advancing medical breakthroughs and ensuring that its innovations benefit patients globally. The new Kendall Square headquarters will not only serve as a home for Biogen but will also represent its commitment to collaboration, innovation, and the community that has supported it for decades.
Frequently Asked Questions
What is Biogen's new headquarters project?
Biogen is developing a new global headquarters at Kendall Common to consolidate its operations and foster collaboration within its teams and partners.
When is the new headquarters scheduled to open?
The new headquarters is set to open in 2028, coinciding with Biogen's 50th anniversary.
What features will the new headquarters include?
The facility will feature advanced laboratories, modern workspaces, and sustainable design elements such as energy-efficient systems.
How will the Biogen CoLab function?
The Biogen CoLab will serve as a collaborative laboratory for Biogen scientists, schools, and nonprofits, aimed at promoting careers in life sciences and healthcare.
Why is this project significant for Massachusetts?
Biogen's new headquarters reinforces Massachusetts' position as a leader in biotechnology and fosters long-term growth and innovation in the life sciences sector.
